PAR — Par Drugs and Chemicals Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Interim Report	ARS	ARS
Standards:	IAS	IAS	—	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	463	558	608	751	957
Cost of Revenue
Gross Profit	138	162	389	463	293
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	412	492	456	621	808
Operating Profit	51.7	66.9	152	130	150
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	32.9	59.9	147	127	151
Provision for Income Taxes
Net Income After Taxes	25.1	47.6	116	92.1	113
Net Income Before Extraordinary Items
Net Income	25.1	47.6	116	92.1	113
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	25.1	47.6	116	92.1	113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	5.6	7.72	16.3	7.49	9.12